Uses of Qaderlo

Qaderlo is used by a doctor's prescription to treat common allergic conditions such as allergic rhinitis or chronic idiopathic urticaria. In order for Qaderlo drug to fully promote all its therapeutic effects, patients need to take the drug according to the schedule recommended by the doctor.

Qaderlo is an antiallergic drug and is often used in cases of hypersensitivity. Qaderlo drug is manufactured by the branch of OPC pharmaceutical joint stock company in Binh Duong - OPC pharmaceutical factory - Vietnam with the dosage form of film-coated tablets and packaged according to the box specification of 3 blisters x 10 tablets.
Qaderlo medicine contains the main ingredient, Desloratadin, 5mg and other auxiliary excipients, just enough for one tablet. Currently, Qaderlo is highly appreciated by a team of leading experts for its ability to effectively treat common allergic conditions such as allergic rhinitis or chronic idiopathic urticaria.

2.1. Uses of the active ingredient Desloratadin Desloratadin is the main ingredient in Qaderlo, which belongs to the second generation of antihistamines, has the effect of reducing itching and anti-allergic, urticaria. Some studies have shown that, when given as a single or repeated dose of Desloratadine 5mg, an antihistamine effect can be obtained after 1 hour and persisted for the next 24 hours.
On the other hand, Desloratadine does not cause drowsiness when used, has a rapid absorption rate after taking into the body. The time for Desloratadine to reach steady-state plasma concentrations is approximately 3 hours after administration. On the other hand, grapefruit juice and food did not affect the bioavailability of the drug.
2.2. Indications, contraindications to the use of Qaderlo drug Qaderlo drug is prescribed to quickly improve the following conditions:
Effectively repel the symptoms of seasonal allergic rhinitis or peri-allergic rhinitis years, such as runny nose, sneezing, stuffy nose, itchy nose, runny nose, watery eyes, red eyes, eye irritation, cough, or itchy throat. Palliative treatment of the symptoms of chronic idiopathic urticaria. However, the use of Qaderlo should be avoided in the following cases without a doctor's prescription:
People with a history of hypersensitivity or allergy to the active ingredient Desloratadine or any of the excipients contained in the drug. . Relative contraindications for pregnant women and nursing mothers.

3.1. Dosage recommendations for Qaderlo The following is the dose of Qaderlo for the treatment of allergic symptoms according to the general recommendations of the doctor:
Dosage for adults and children over 12 years: Take a dose of 5mg / time / day. Dose for children from 6 to 11 years old: Take 2.5mg/time/day. Dose for patients with renal or hepatic impairment: Initial oral dose is 5 mg and intervals are based on assessment of pharmacokinetics. 3.2. How to use Qaderlo Because it is in the form of film-coated tablets, Qaderlo will be taken orally at the dose prescribed by your doctor. For patients with intermittent allergic rhinitis whose symptoms persist for less than 4 days/week or for less than 4 weeks, treatment with Qaderlo should be based on the physician's evaluation of the medical history. In addition, this patient population may consider discontinuing Qaderlo treatment when symptoms have resolved and re-treatment if symptoms reappear.
For patients with persistent allergic rhinitis whose symptoms persist for more than 4 days/week and persist for more than 4 weeks, Qaderlo may be treated continuously during allergen exposure.
In general, patients need to apply the exact dose of Qaderlo as recommended by their doctor in all cases. Avoid arbitrarily applying, changing the dose or prolonging the allowed treatment time.
If you accidentally overdose on Qaderlo, the patient should notify the doctor immediately for remedial measures. Normally, standard measures to remove the unabsorbed portion of Desloratadine from the body would be considered. In addition, patients with an overdose of Desloratadine should also receive supportive and symptomatic treatment.

In fact, Qaderlo drug rarely causes side effects for patients during treatment. Certain cases may experience symptoms such as dry mouth, fatigue, headache, itchy rash or anaphylaxis. In addition, very rarely Qaderlo drug causes side effects such as increased liver enzymes, increased bilirubin, hepatitis, seizures, increased psychomotor activity, tachycardia, palpitations or skin rash.
When the body notices any strange reactions after taking Qaderlo, the patient should stop the treatment and immediately go to the medical facility for treatment.

During the use of Qaderlo, patients should carefully note some of the following general recommendations to ensure safety and effectiveness when taking the drug:
Use caution when administering Qaderlo to patients with a history of or are suffering from diseases such as myasthenia gravis, stomach ulcers, hepatic coma or other chronic diseases. Qaderlo should be used with caution in the elderly because the physiological function of this patient has decreased. Qaderlo should only be used by pregnant or nursing women when the benefits outweigh the potential risks. It is important to be aware of the potential for interactions when taking Qaderlo at the same time as other drugs such as Cimetidine, Ketoconazole, Erythromycin or Azithromycin. Patients should inform their physician of the current list of medications they are taking to prevent possible drug interactions. Always check the expiry date of Qaderlo carefully before using it to avoid the risk of taking an expired medicine. Carefully check the quality, color and shape of the drug, if the drug shows signs of color change, deformation or watery, the patient needs to stop using and discard the drug as prescribed. The basic information about the drug Qaderlo in the above article is for reference only. Because this is a prescription drug, patients should not use it on their own, but need to contact a specialist directly to get an appropriate prescription to ensure safety for health.